在癌症治疗中,单核酸多态度介导的介素-6受体阻塞的治疗潜力:孟德尔的随机化研究
Shuwan Zhang1,2, Wenchuan Zhang1,3, Hanxue Sun1
1Department of Pathology, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China.
Heliyon
|October 9, 2023
概括
干白素-6受体 (IL-6R) 阻断在治疗几种癌症方面表现有前途,但增加了其他癌症的风险. 这项孟德尔随机化研究评估了IL-6R阻断.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 洲际蛋白-6 (IL-6) 是一种关键的细胞因子,与癌症发展有关.
- 阻断IL-6受体 (IL-6R) 是一种治疗策略,但其抗癌疗效尚不清楚.
研究的目的:
- 评估IL-6R阻断对各种癌症类型的因果影响,使用孟德尔随机化方法.
- 评估基于单核酸多态 (SNP) 的IL-6R阻断在癌症治疗中的潜力和有效性.
主要方法:
- 进行了反向方差加权的门德尔随机化 (MR) 分析.
- 用于药物向的SNP在IL-6R基因300kB以内被用作仪器变量.
- 分析了来自FinnGen全基因组关联研究的数据,包括33种癌症类型.
主要成果:
- IL-6R阻断在膀,喉,眼睛,胆囊和骨髓性白血病中表现出治疗效果.
- 相反,IL-6R阻塞与基础细胞癌和黑色素瘤的风险增加有关.
- 敏感性分析证实了初步发现,没有显著的变化.
结论:
- 基于SNP的IL-6R阻断显示了双重效应,为某些癌症提供治疗效益,同时增加其他癌症的风险.
- 需要进一步的研究来完善IL-6R阻断策略,以获得最佳的癌症治疗.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
15.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


